Scanbutazone en es it fr

Scanbutazone Brand names, Scanbutazone Analogs

Scanbutazone Brand Names Mixture

  • Alka Phenyl Tab (Aluminum Hydroxide + Magnesium Trisilicate + Phenylbutazone)
  • Alka Phenylbutazone Tab (Aluminum Hydroxide + Magnesium Trisilicate + Phenylbutazone)
  • Phenylone Plus Tab (Aluminum Hydroxide + Magnesium Trisilicate + Phenylbutazone)

Scanbutazone Chemical_Formula

C19H20N2O2

Scanbutazone RX_link

No information avaliable

Scanbutazone fda sheet

Scanbutazone msds (material safety sheet)

Scanbutazone MSDS

Scanbutazone Synthesis Reference

Ullmann's Encyklopaedie der Technischen Chemie 13, 298 (1962)

Scanbutazone Molecular Weight

308.374 g/mol

Scanbutazone Melting Point

105 oC

Scanbutazone H2O Solubility

47.5 mg/L

Scanbutazone State

Solid

Scanbutazone LogP

4.214

Scanbutazone Dosage Forms

Bolus; Liquid; Paste; Powder; Solution; Tablet

Scanbutazone Indication

For the treatment of backache and ankylosing spondylitis

Scanbutazone Pharmacology

Phenylbutazone is a synthetic, pyrazolone derivative. It is a nonhormonal anti-inflammatory, antipyretic compound useful in the management of inflammatory conditions. The apparent analgesic effect is probably related mainly to the compound's anti-inflammatory properties and arise from its ability to reduce production of prostaglandin H and prostacyclin. Prostaglandins act on a variety of cells such as vascular smooth muscle cells causing constriction or dilation, on platelets causing aggregation or disaggregation and on spinal neurons causing pain. Prostacylcin causes vascular constriction platelet disaggregation

Scanbutazone Absorption

No information avaliable

Scanbutazone side effects and Toxicity

Oral, LD50 = 238 mg/kg (mouse); Oral, LD50 = 781 mg/kg (rabbit); Oral, LD50 = 245 mg/kg (rat); Oral, LD50 = 375 mg/kg (rat)

Scanbutazone Patient Information

No information avaliable

Scanbutazone Organisms Affected

Humans and other mammals